The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.
The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
The commercial production in the SML was started in November 1989.
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
The Trivitron Healthcare CMD and FICCI Tamil Nadu Chairman was honoured for advancing indigenous innovation and strengthening India's healthcare ecosystem
Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
Subscribe To Our Newsletter & Stay Updated
